Joel M. Linden

Joel M. Linden

Company: Adovate

Job title: Chief Scientific Officer


Next Generation Adenosine Therapeutics for A2B 1:30 pm

Explain the biological importance of A2B Discuss the development route for A2B therapeutics and current challenges/opportunitiesRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.